AVEO Oncology
AVEO
#7373
Rank
NZ$0.92 B
Marketcap
NZ$26.55
Share price
0.00%
Change (1 day)
190.63%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -NZ$44.46 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are NZ$94.31 Million. In 2021 the company made an earning of -NZ$94.43 Million a decrease over its 2020 earnings that were of -NZ$62.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$44.46 Million-52.92%
2021 -NZ$94.43 Million49.9%
2020 -NZ$62.99 Million-479.04%
2019 NZ$16.61 M-276.17%
2018 -NZ$9.44 Million-91.79%
2017 -NZ$0.12 Billion142.38%
2016 -NZ$47.42 Million78.51%
2015 -NZ$26.57 Million-71.55%
2014 -NZ$93.36 Million-50.72%
2013 -NZ$0.19 Billion-4.88%
2012 -NZ$0.2 Billion-426.29%
2011 NZ$61.04 M-159.85%
2010 -NZ$0.11 Billion35.33%
2009 -NZ$75.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$55.09 B-107,283.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.08 B-31,392.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.87 B-5,689.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$9.12 B-17,858.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.98 B-33,148.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$4 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA